-- Phase 1 clinical trial will evaluate the safety, tolerability, and pharmacokinetics -- SBS-147 is a novel and potent oral analgesic with a differentiated safety profile being developed for acute ...
Clinical Trials Arena on MSN
Sparian commences phase I trial of SBS-147 for pain treatment
The therapy’s development from Phase I to Phase II is funded by a $15m NIH/NIDA HEAL grant.
SBS has announced that the new season of ‘Who Do You Think You Are?’ will premiere on 12 May, featuring the likes of Guy ...
SBS-147 is a novel and potent oral analgesic with a differentiated safety profile being developed for acute and chronic pain The phase 1 SAD/MAD and phase 2 clinical study of SBS-147 are supported by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results